MedPath

Effect of Flumazenil Drip On Speed Of Recovery And Prevention Of Complications In Severe Acute Benzodiazepine Toxicity

Phase 2
Conditions
Poisoning by, adverse effect of and underdosing of hydantoin derivatives
T42.0
Benzodiazepine poisoning.
Registration Number
IRCT20120629010133N3
Lead Sponsor
IMAD (National Institute for Medical Research Development)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Severely benzodiazepine-poisoned patients (in need for intubation and mechanical ventilation) with otherwise normal vital signs

Exclusion Criteria

Abnormal vital signs on presentation,
history of seizure,
history of ingestion or use of any drug/medication that can predispose the patient to seizure,
history of head trauma,
possible brain edema and increased intracranial pressure,
history of hypoxemia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mortality-. Timepoint: 7 days after admission. Method of measurement: Observation and questionnaire recording.;Complications during hospitalization. Timepoint: 7 days after admission. Method of measurement: Observation and questionnaire recording.;Intubation. Timepoint: 7 days after admission. Method of measurement: Observation and questionnaire recording.
Secondary Outcome Measures
NameTimeMethod
Hospitalization period. Timepoint: At discharge or death. Method of measurement: Observation and questionnaire recording.
© Copyright 2025. All Rights Reserved by MedPath